Tiger
Download
TigerAI
Help
LOGIN
SIGN UP
Toggle
KEYMED BIO-B's 2026Q1 financial report review
HK
02162
Mar26th Thursday
Earnings Overview
Financial Data
Actual
YoY
Estimates
EPS
-1.65
-
-1.31
Revenue
217.56M
-
338.43M
EBIT
-477.88M
-
-337.88M
News
In-Depth Insights
The above content is machine - summarized based on the financial report. It is for reference only, does not constitute investment advice, and does not guarantee accuracy.
Market Insights
What's the highlight of KEYMED BIO-B's financial report?
Talk to TigerAI
Start
Exclusive Benefits
Analyst Forecast
KEYMED BIO-B
HK
02162
Mar26th Thursday
Analyst Price Targets
Data Last updated:
Analyst Recommendations
Relevant Information
Feedback
Welcome to share with us your comments or feedback
*T&Cs Apply. Capital at Risk, Not Investment Advice.
Learn more
{"basename":"/earnseason","ssrTDKData":{"titleTemplate":"%s","title":"Tiger Trade _ US, HK & SG stocks, ETFs & US options","description":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","keywords":"Tiger Trade,US stock trading,Hong Kong stock trading,Singapore trading,US stocks,top US stocks,stock information,stock prices,US stock quotes,buying US stocks,global investment,trading,trading platform,US options,ETFs","social":{"ogDescription":"A top trading platform from a NASDAQ listed company enables investors to invest in the global giants from only USD 1, and here you can access to investment products including US stocks, SG stocks, HK stocks, ETFs, US options, US fractional shares & auto invest on multiple global markets including Nasdaq, New York Stock Exchange, Hong Kong Stock Exchange & Singapore Stock Exchange","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigertrade.app/earnseason/02162"},"companyName":"Tiger"},"pageData":{"pageTitle":"KEYMED BIO-B (02162) Earnings Calendar_Earnings Analysis_Financial Report and Earnings Call","headTitle":"KEYMED BIO-B's 2026Q1 financial report review","feedBackDisplay":true,"financialNewsMaxNum":3,"keyData":[{"nameChs":"调整后每股收益","nameCht":"調整後每股收益","nameEng":"EPS","actualValue":-1.65,"expectedValue":-1.31,"name":"EPS"},{"nameChs":"收入","nameCht":"收入","nameEng":"Revenue","actualValue":217561000,"expectedValue":338425000,"name":"Revenue"},{"nameChs":"息税前利润","nameCht":"息稅前利潤","nameEng":"EBIT","actualValue":-477882000,"expectedValue":-337885000,"name":"EBIT"}],"tigerGpt":{"internalJumpUrl":null,"externalJumpUrl":null},"beforeOrAfter":"after","shareConfig":{"socialMediaImage":"https://static.tigerbbs.com/461bf91ab2e2283e68395ea16fd95e8e","weChatImage":"https://static.tigerbbs.com/55353f4879f69c699f0109fe402ca704","title":"KEYMED BIO-B's Earnings Preview","description":"View key performance metrics of KEYMED BIO-B's earnings in one chart and explore more opportunities."},"analystRecommendations":[{"market":"HK","symbol":"02162","logo":"https://static.tigerbbs.com/86aaf26b2d6dc5b2439420dac534ca6e","reportTime":"","isReport":true,"date":"20260326","nameEng":"KEYMED BIO-B","timestamp":1774454400000,"name":"KEYMED BIO-B"}],"stockInfo":{"market":"HK","symbol":"02162","logo":"https://static.tigerbbs.com/86aaf26b2d6dc5b2439420dac534ca6e","reportTime":"","isReport":true,"date":"20260326","timestamp":1774454400000,"name":"KEYMED BIO-B","nameEng":"KEYMED BIO-B"}},"pageError":null,"isTTM":true,"isTigerTrade":false,"isTigerTradeLite":false,"license":"TBMS","region":"IDN","edition":"full_ms","isOpenedInApp":true}